2
Clinical Trials associated with TSI-GSD-210Phase 2 Open-Label Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, Dried, TSI-GSD 210, Lot 3-1-92, in Healthy Adult Subjects at Risk of Exposure to Western Equine Encephalitis Virus
This study is being conducted to collect safety and immunogenicity data for the WEE vaccine, TSI-GSD 210. Enrollment in this protocol is offered for personnel who enter areas where this virus is used in research or is endemic (an area where this disease process is found to occur frequently).
Phase 1 Study to Evaluate the Safety and Immunogenicity of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, TSI-GSD 210, Lot 3-1-92, In Healthy Adults
This study is designed to determine the safety and immunogenicity of WEE Vaccine Lot number 3-1-92.
100 Clinical Results associated with TSI-GSD-210
100 Translational Medicine associated with TSI-GSD-210
100 Patents (Medical) associated with TSI-GSD-210
100 Deals associated with TSI-GSD-210